L3Harris Technologies, Inc. filed an 8-K with the U.S. Securities and Exchange Commission on August 17, 2026, disclosing the appointment of Sam Mehta as President and Chief Executive Officer effective immediately, alongside the separation of former Chairman and CEO Christopher Kubasik following a Board …
D-Wave Quantum Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission on August 17, 2026, disclosing the appointment of Kevan P. Krysler as an independent Class I director, effective August 13, 2026.
News Corporation filed a Form 8-K on August 17, 2026, reporting its required daily disclosures to the Australian Securities Exchange regarding transactions conducted under the company's stock repurchase program.
Strive, Inc. filed a Form 8-K on August 17, 2026, disclosing a bitcoin purchase of 79 coins made between August 10 and August 14, 2026, along with a full update of the company's holdings and share counts as of August 14, 2026.
HIVE Digital Technologies Ltd. filed a Form 8-K with the SEC on August 15, 2026, furnishing a press release announcing its financial results for the three and six months ended June 30, 2026.
Strategy Inc filed an 8-K current report on August 17, 2026, disclosing weekly at-the-market offering activity, bitcoin holdings, share repurchase program updates, and the balance of its USD Reserve as of August 16, 2026.
Bakkt, Inc. filed a Form 8-K on August 17, 2026, reporting the departure of Chief Financial Officer Karen Alexander effective August 14, 2026, and the appointment of Matt White as CFO effective August 17, 2026, both disclosed under Item 5.02.
WhiteFiber, Inc. filed a Form 8-K with the SEC on August 17, 2026, disclosing that its wholly owned subsidiary entered into a Real Estate Purchase and Sale Agreement on August 16, 2026, to acquire industrial property in Yadkin County, North Carolina, for a cash …
ScanSource, Inc. filed a Form 8-K with the SEC on August 17, 2026, disclosing the retirement of long-serving board director Peter C. Browning, effective August 12, 2026.
Anavex Life Sciences Corp. filed a Form 8-K with the SEC on August 17, 2026, disclosing under Regulation FD that it had issued a press release and mailed a letter to stockholders in connection with its 2026 Annual Meeting of Stockholders.